Related references
Note: Only part of the references are listed.Association of ABCB1 gene polymorphisms and haplotypes with therapeutic efficacy of glucocorticoids in Chinese patients with immune thrombocytopenia
Min Xuan et al.
HUMAN IMMUNOLOGY (2014)
The presence of KIR2DS5 confers protection against adult immune thrombocytopenia
L. A. Seymour et al.
TISSUE ANTIGENS (2014)
The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms
Jamie P. Nourse et al.
BLOOD COAGULATION & FIBRINOLYSIS (2012)
ITP in Children
John A. D’Orazio et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2012)
Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome
Yee-Hsuan Chiou et al.
PEDIATRIC NEPHROLOGY (2012)
Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters
Lisa J. Toltl et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Relation between 3435C>T multidrug resistance 1 gene polymorphism with high dose methylprednisolone treatment of childhood acute idiopathic thrombocytopenic purpura
Mehmet Akin et al.
GENE (2011)
MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children
Tabrez Jafar et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura
M. Pehlivan et al.
PLATELETS (2011)
Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome
Hyun Jin Choi et al.
PEDIATRIC NEPHROLOGY (2011)
The role of tumor necrosis factor-alpha-308 G/A and transforming growth factor-beta 1-915 G/C polymorphisms in childhood idiopathic thrombocytopenic purpura
Emel Okulu et al.
TURKISH JOURNAL OF HEMATOLOGY (2011)
Genetic studies in pediatric ITP: outlook, feasibility, and requirements
Anke K. Bergmann et al.
ANNALS OF HEMATOLOGY (2010)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
Francesco Zaja et al.
BLOOD (2010)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
The ITP syndrome: pathogenic and clinical diversity
Douglas B. Cines et al.
BLOOD (2009)
Association of killer cell immunoglobulin-like receptors with primary Sjgrens syndrome
David P. Lowe et al.
RHEUMATOLOGY (2009)
Multidrug resistance-1 in T lymphocytes and natural killer cells of adults with idiopathic thrombocytopenic purpura:: Effect of prednisone treatment
Xavier Lopez-Karpovitch et al.
ARCHIVES OF MEDICAL RESEARCH (2008)
Association of inflammatory cytokine gene polymorphisms with platelet recovery in idiopathic thrombocytopenic purpura patients after the eradication of Helicobacter pylori
Takayoshi Suzuki et al.
DIGESTION (2008)
Epidemiology and pathophysiology of immune thrombocytopenic purpura
Terry Gernsheimer
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura
Willernijn B. Breunis et al.
BLOOD (2008)
NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement
Siao-Yi Wang et al.
BLOOD (2008)
Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease
R. J. Boyton et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
A silent polymorphism in the MDR1 gene changes substrate specificity
Chava Kimchi-Sarfaty et al.
SCIENCE (2007)
The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs
Marek Drozdzik et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Childhood ITP:: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS)
P Imbach et al.
PEDIATRIC BLOOD & CANCER (2006)
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
DX Wang et al.
PHARMACOGENETICS AND GENOMICS (2005)
Multi-dysfunctional pathophysiology in ITP
B Zhou et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
P-glycoprotein in autoimmune diseases
Y Richaud-Patin et al.
AUTOIMMUNITY REVIEWS (2004)
Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein
K Dilger et al.
INFLAMMATORY BOWEL DISEASES (2004)
Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene
H Takane et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The MDR1 (ABCB1) gene polymorphism and its clinical implications
I Ieiri et al.
CLINICAL PHARMACOKINETICS (2004)
Cutting edge: Heterozygote advantage in autoimmune disease: Hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis
GW Nelson et al.
JOURNAL OF IMMUNOLOGY (2004)
Association of killer cell immunoglobulin-like receptors with scleroderma
T Momot et al.
ARTHRITIS AND RHEUMATISM (2004)
KIR in type 1 diabetes: Disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects
AR van der Slik et al.
DIABETES (2003)
T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura
B Olsson et al.
NATURE MEDICINE (2003)
Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene
DL Kroetz et al.
PHARMACOGENETICS (2003)
Pharmacogenetics of MDR1 and its impact on the pharmacokinetics of drugs and pharmacodynamics
T Sakaeda et al.
PHARMACOGENOMICS (2003)
Multidrug resistance-1 (MDR-1) in autoimmune disorders III:: Increased P-glycoprotein activity in lymphocytes from immune thrombocytopenic purpura patients
R Ruiz-Soto et al.
EXPERIMENTAL HEMATOLOGY (2003)
Association of the P-glycoprotein transporter MDR1C3435T polymorphism with the susceptibility to renal epithelial tumors
M Siegsmund et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Involvement of Fcγ receptor polymorphism in the therapeutic response of idiopathic thrombocytopenic purpura
TT Fujimoto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement
B Huard et al.
NATURE (2000)
Share Paper
